Lung Cancer Educational 3-Part Webinar Series

Availability

On-Demand

Access expires on 06/30/2024

Credit Offered

No Credit Offered

Webinar # 1:
Title: What is biomarker testing for advanced lung cancer and why is it important?

Description: Introduction to biomarker testing and NSCLC. Define biomarker testing, comprehensive testing, provide examples of therapies and local/metastatic indications for use based on trials/FDA approvals early and advanced stage, and illustrate improved outcomes.

Moderator:
Adam H. Fox, MD MS
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, SC

Speaker: Bruce Johnson, MD
Institute Physician, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

Webinar #2:
Title: Tissue is the issue: Using EBUS to acquire and process tissue for biomarker testing for advanced lung cancer

Description: Best practices for balancing diagnosis, staging, and tissue for testing. Role of EBUS and biomarker testing. Cover success rates reported in literature for different biopsy modalities. Role of ROSE, cover special scenarios (effusions, bone metes, brain mets, etc.) Considerations for QNS results: ct-DNA, re-biopsy.

Moderator:
Gerard A. Silvestri, MD MS
Hillenbrand Professor of Thoracic Oncology
Senior Vice-Chair of Faculty Development
Department of Medicine
Medical University of South Carolina
Charleston, SC

Speaker:
Nicholas J. Pastis MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The Ohio State University
Columbus, OH

Webinar 3:
Title: Establishing a program to perform lung cancer biomarker testing: Shortening the time from patient presentation to treatment

Description: Describe metrics of success/best practices and collaborations for biomarker testing programs. Dr. Sholl will cover tissue handling and pathology perspectives on turnaround time. Dr. Fox will cover reflex testing and multi-disciplinary coordination to improve turnaround time as well as the role of biomarker testing for earlier stages of lung cancer.

Moderator:
Gerard A. Silvestri, MD MS
Hillenbrand Professor of Thoracic Oncology
Senior Vice-Chair of Faculty Development
Department of Medicine
Medical University of South Carolina
Charleston, SC

Speakers:
Lynette M. Sholl MD
Department of Pathology
Brigham and Women's Hospital
Boston, MA

Adam H. Fox, MD MS
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, SC

Checklist:
Title: Enhancing NSCLC Biomarker Testing: Introducing a Practical Clinician Checklist

Description: In a live CHEST webinar, Gerard A. Silvestri, MD, MS, and Adam H. Fox, MD, MS, will unveil a new clinician checklist designed to enhance biomarker testing for patients with non-small cell lung cancer (NSCLC). This informative session will delve into the methodology employed to tackle practice gaps in tissue sampling, processing/testing, and interdisciplinary coordination. Learn how to leverage this practical checklist to improve patient care and outcomes, and discover ways to actively participate in quality improvement initiatives.